TrialAdvances in therapy2013

Evaluation of a new formulation of epoprostenol sodium in Japanese patients with pulmonary arterial hypertension (EPITOME4).

Yuichi Tamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.